Cargando…

The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer

INTRODUCTION: Sentinel lymph node (SLN) metastasis is an important predictor of prognosis in breast cancer (BC) patients, guiding treatment decisions. However, patients with the same BC subtype and tumor negative SLN (SLNneg) can have different survival outcomes. We hypothesized that the host anti-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kooreman, Loes F. S., Dieleman, Sabine, van Kuijk, Sander M. J., zur Hausen, Axel, Smidt, Marjolein L., Grabsch, Heike I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642264/
https://www.ncbi.nlm.nih.gov/pubmed/37965336
http://dx.doi.org/10.3389/fimmu.2023.1258641
_version_ 1785146929921916928
author Kooreman, Loes F. S.
Dieleman, Sabine
van Kuijk, Sander M. J.
zur Hausen, Axel
Smidt, Marjolein L.
Grabsch, Heike I.
author_facet Kooreman, Loes F. S.
Dieleman, Sabine
van Kuijk, Sander M. J.
zur Hausen, Axel
Smidt, Marjolein L.
Grabsch, Heike I.
author_sort Kooreman, Loes F. S.
collection PubMed
description INTRODUCTION: Sentinel lymph node (SLN) metastasis is an important predictor of prognosis in breast cancer (BC) patients, guiding treatment decisions. However, patients with the same BC subtype and tumor negative SLN (SLNneg) can have different survival outcomes. We hypothesized that the host anti-tumor immune reaction in SLNneg is important and results in morphometrically measurable changes in SLN size or shape which are related to patient prognosis. METHODS: Surface area, circumference, long axis and short axis were histologically measured in 694 SLNneg from 356 cases of invasive BC and 67 ductal carcinoma in situ cases. The area occupied by fat was categorized as less or more than 50%. The long to short axis (L/S) ratio was calculated. The relationship between SLNneg morphometries and clinicopathological variables like tumor-infiltrating lymphocytes (TILs) within the primary tumor, as well as prognosis at 10 years follow up were analyzed. RESULTS: The mean SLNneg surface area was 78.7mm(2), circumference 40.3mm, long axis 13.1mm, short axis 8.2mm and L/S ratio 1.7. Larger surface area, long axis and short axis, including age >55 years were associated with higher body mass index (BMI) and SLN fat over 50% (p<0.003). In invasive BC, a high SLNneg L/S ratio (≥1.9) was related to poorer disease-free (HR=1.805, 95%CI 1.182-2.755, p=0.006) and overall (HR=2.389, 95%CI 1.481-3.851, p<0.001) survival. A low SLNneg L/S ratio (<1.9) was associated with high TILs in the primary BC (≥10%) (p=0.005). However a high TIL count was not of prognostic relevance. CONCLUSIONS: This is the first study to suggest that morphometric characteristics of axillary SLNneg, like L/S ratio, could be used to predict prognosis in patients with SLNneg invasive BC of all subtypes. The association between low L/S ratio and high TILs suggest that SLN shape is related to immunological functioning of the SLN and could be used in addition to TIL evaluation. Regarding the dubious role of TILs in hormone receptor positive breast cancer, SLNneg morphometry to gain information about host immune status could especially be of benefit in this subtype. Further studies are warranted to better understand the underlying biological mechanisms.
format Online
Article
Text
id pubmed-10642264
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106422642023-11-14 The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer Kooreman, Loes F. S. Dieleman, Sabine van Kuijk, Sander M. J. zur Hausen, Axel Smidt, Marjolein L. Grabsch, Heike I. Front Immunol Immunology INTRODUCTION: Sentinel lymph node (SLN) metastasis is an important predictor of prognosis in breast cancer (BC) patients, guiding treatment decisions. However, patients with the same BC subtype and tumor negative SLN (SLNneg) can have different survival outcomes. We hypothesized that the host anti-tumor immune reaction in SLNneg is important and results in morphometrically measurable changes in SLN size or shape which are related to patient prognosis. METHODS: Surface area, circumference, long axis and short axis were histologically measured in 694 SLNneg from 356 cases of invasive BC and 67 ductal carcinoma in situ cases. The area occupied by fat was categorized as less or more than 50%. The long to short axis (L/S) ratio was calculated. The relationship between SLNneg morphometries and clinicopathological variables like tumor-infiltrating lymphocytes (TILs) within the primary tumor, as well as prognosis at 10 years follow up were analyzed. RESULTS: The mean SLNneg surface area was 78.7mm(2), circumference 40.3mm, long axis 13.1mm, short axis 8.2mm and L/S ratio 1.7. Larger surface area, long axis and short axis, including age >55 years were associated with higher body mass index (BMI) and SLN fat over 50% (p<0.003). In invasive BC, a high SLNneg L/S ratio (≥1.9) was related to poorer disease-free (HR=1.805, 95%CI 1.182-2.755, p=0.006) and overall (HR=2.389, 95%CI 1.481-3.851, p<0.001) survival. A low SLNneg L/S ratio (<1.9) was associated with high TILs in the primary BC (≥10%) (p=0.005). However a high TIL count was not of prognostic relevance. CONCLUSIONS: This is the first study to suggest that morphometric characteristics of axillary SLNneg, like L/S ratio, could be used to predict prognosis in patients with SLNneg invasive BC of all subtypes. The association between low L/S ratio and high TILs suggest that SLN shape is related to immunological functioning of the SLN and could be used in addition to TIL evaluation. Regarding the dubious role of TILs in hormone receptor positive breast cancer, SLNneg morphometry to gain information about host immune status could especially be of benefit in this subtype. Further studies are warranted to better understand the underlying biological mechanisms. Frontiers Media S.A. 2023-10-30 /pmc/articles/PMC10642264/ /pubmed/37965336 http://dx.doi.org/10.3389/fimmu.2023.1258641 Text en Copyright © 2023 Kooreman, Dieleman, van Kuijk, zur Hausen, Smidt and Grabsch https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Kooreman, Loes F. S.
Dieleman, Sabine
van Kuijk, Sander M. J.
zur Hausen, Axel
Smidt, Marjolein L.
Grabsch, Heike I.
The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer
title The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer
title_full The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer
title_fullStr The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer
title_full_unstemmed The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer
title_short The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer
title_sort prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642264/
https://www.ncbi.nlm.nih.gov/pubmed/37965336
http://dx.doi.org/10.3389/fimmu.2023.1258641
work_keys_str_mv AT kooremanloesfs theprognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT dielemansabine theprognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT vankuijksandermj theprognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT zurhausenaxel theprognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT smidtmarjoleinl theprognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT grabschheikei theprognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT kooremanloesfs prognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT dielemansabine prognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT vankuijksandermj prognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT zurhausenaxel prognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT smidtmarjoleinl prognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer
AT grabschheikei prognosticvalueofthehistologicalshapeoftumornegativesentinelnodesinbreastcancer